Complife Group is a company made up of passionate research professionals, often involved in innovative industry studies.
The most recent study on the cutaneous microbiome will be presented by Dr. Clemence Robert, starting this week, at the most important trade conferences, such as:
| Congresso nazionale della società italiana di microbiologia
16th-17th / 20th-21th september 2021
| Targeting Microbiota
Paris, 20th-22nd october 2021 – 8th worldwide congress on targeting microbiota
| Microbiome R&D & Business Collaboration Forum
Rotterdam, 26th-27th october 2021 – presentation speech in collaboration with Copan
The presence at the conferences is fundamental for the team of Complife, which strongly believes in the constant updating with respect to new developments in the scientific field.
In addition, the sharing of studies and their results with other professionals promotes professional enrichment and allows to be increasingly active in RESEARCH & DEVELOPMENT.
“VARIATIONS OF THE CUTANEOUS FACIAL MICROBIOME DEPENDING ON ENDOGENOUS AND EXOGENOUS FACTORS” is the study in question, developed in collaboration with Copan and written by:
Dr. Clemence ROBERT – Complife Italy, UPO
Pr. Elisa BONA – UPO
Dr. Vincenzo NOBILE – Complife
THIS PAPER REVEALS SOME EXCITING DISCOVERIES IN THE FIELD OF FACIAL MICROBIOME AND HOW THIS IS HIGHLY VARIABLE AND IS INFLUENCED BY ENDOGENOUS AND EXOGENOUS FACTORS.
THE STUDY – ONE OF THE FEW CARRIED OUT IN EUROPE – WAS CONDUCTED IN ITALY, ON A PANEL OF 183 PEOPLE (159 WOMEN AND 71 MEN), ALL BETWEEN 18 AND 71 YEARS OF AGE.
Two endogenous factors are examined – sex and age – and two exogenous factors – season and area – and interesting variations of the microbiome are observed as both factors vary.
The full report on this study will be presented at the congresses mentioned above.
Complife Group can boast a team of professionals with high scientific expertise, to assist its customers in the quality and safety assessments of products.
The strong drive for innovation that characterizes the company’s approach also ensures complete support in the formulation of the best successful strategy.
COMPLIFE. COMMITTED TO SCIENCE. COMMITTED TO YOU.
